Header cover image
  • Investing Ideas
  • /
  • Nigerian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Nigerian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

May & Baker Nigeria

Market Cap: ₦30.7b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦17.80

7D

7.9%

1Y

108.2%